Clinical Trial Update: Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating ketone bodies and epigallocatechin gallate in multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Fundación Universidad Católica de Valencia San Vicente Mártir | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED